Vonlerolizumab Antibody
Vonlerolizumab (MOXR 0916) is a humanized agonistic anti-OX40 monoclonal antibody. It is designed to activate T-cells and is utilized in preclinical oncology and immunology research, including studies on tumor models and autoimmune conditions in both in vitro and in vivo experimental settings.
Product Specifications
Product Name Alternative
MOXR 0916, MOXR0916, MOXR-0916, Vonlerolizumab, Pogalizumab, RG7888, RG-7888, RG 7888
Target
Others, TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
3.98 mg/mL
Purity
97.90% (May vary between batches)
Molecular Weight
145.25 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041870-500 1x 500 µL
CD10 (Membrane Metalloendopeptidase) (MME/1870), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402818-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2818R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC810018-500 1x 500 µL
Human Kappa Light Chain (L1C1), CF680R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681761-500 1x 500 µL
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details